Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an FGFR3 Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary Phenotype
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cancers 12.3 (2020): 763.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2020
- Urheber
-
Weyerer, Veronika
Eckstein, Markus
Compérat, Eva
Juette, Hendrik
Gaisa, Nadine T.
Allory, Yves
Stöhr, Robert
Wullich, Bernd
Rouprêt, Morgan
Hartmann, Arndt
Bertz, Simone
- DOI
-
10.3390/cancers12030763
- URN
-
urn:nbn:de:bvb:29-opus4-136076
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Weyerer, Veronika
- Eckstein, Markus
- Compérat, Eva
- Juette, Hendrik
- Gaisa, Nadine T.
- Allory, Yves
- Stöhr, Robert
- Wullich, Bernd
- Rouprêt, Morgan
- Hartmann, Arndt
- Bertz, Simone
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2020
Ähnliche Objekte (12)
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma
Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing
Development of a novel immunocompetent murine tumor model for urothelial carcinoma using in vivo electroporation
CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
Digital volumetric assessment of CIS and tumor mass compliments conventional histopathological assessment in muscle-invasive urothelial bladder cancer
Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients
Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients
Author Correction: CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
Bonn und Vorgebirge
HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevance
Molecular classification of urothelial bladder carcinoma
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma
Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing
Development of a novel immunocompetent murine tumor model for urothelial carcinoma using in vivo electroporation
CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
Digital volumetric assessment of CIS and tumor mass compliments conventional histopathological assessment in muscle-invasive urothelial bladder cancer
Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients
Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients
Author Correction: CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
Bonn und Vorgebirge
HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevance
Molecular classification of urothelial bladder carcinoma
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinoma
Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing
Development of a novel immunocompetent murine tumor model for urothelial carcinoma using in vivo electroporation
CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
Digital volumetric assessment of CIS and tumor mass compliments conventional histopathological assessment in muscle-invasive urothelial bladder cancer
Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients
Piwi-like 1 and -2 protein expression levels are prognostic factors for muscle invasive urothelial bladder cancer patients
Author Correction: CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
Bonn und Vorgebirge
HLA-G expression associates with immune evasion muscle-invasive urothelial cancer and drives prognostic relevance